Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("second-line therapy")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 64

  • Page / 3
Export

Selection :

  • and

Mortality after failure of antiretroviral therapy in sub-Saharan AfricaKEISER, Olivia; TWEYA, Hannock; SCHECHTER, Mauro et al.TM & IH. Tropical medicine & international health. 2010, Vol 15, Num 2, pp 251-258, issn 1360-2276, 8 p.Article

Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapyUYGUN, Ahmet; MELIH OZEL, A; YILDIZ, Oguzhan et al.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 1, pp 42-45, issn 0815-9319, 4 p.Article

Adult medulloblastoma: Prognostic factors and response to therapy at diagnosis and at relapseHERRLINGER, Ulrich; STEINBRECHER, Andreas; WELLER, Michael et al.Journal of neurology. 2005, Vol 252, Num 3, pp 291-299, issn 0340-5354, 9 p.Article

Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa-The IeDEA Southern Africa CollaborationDAVIES, Mary-Ann; MOULTRIE, Harry; BOULLE, Andrew et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, Num 3, pp 270-278, issn 1525-4135, 9 p.Article

Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study)KOIZUMI, W; TANABE, S; NAKAYAMA, N et al.Journal of clinical pharmacy and therapeutics (Print). 2010, Vol 35, Num 3, pp 303-307, issn 0269-4727, 5 p.Article

High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South AfricaFOX, Matthew P; IVE, Prudence; LONG, Lawrence et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 4, pp 500-506, issn 1525-4135, 7 p.Article

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia: A Review of Tyrosine Kinase InhibitorsJABBOUR, Elias; CORTES, Jorge; KANTARJIAN, Hagop et al.Cancer. 2011, Vol 117, Num 5, pp 897-906, issn 0008-543X, 10 p.Article

Combination of paclitaxel and carboplatin as second- line therapy for patients with metastatic melanomaRAO, Ravi D; HOLTAN, Shernan G; INGLE, James N et al.Cancer. 2006, Vol 106, Num 2, pp 375-382, issn 0008-543X, 8 p.Article

Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, MalawiVORKAS, Charles K; TWEYA, Hannock; MZINGANJIRA, Dalitso et al.TM & IH. Tropical medicine & international health. 2012, Vol 17, Num 2, pp 169-176, issn 1360-2276, 8 p.Article

Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG―0803)WU, Y.-L; ZHOU, C; YANG, J.-J et al.Annals of oncology. 2013, Vol 24, Num 4, pp 993-999, issn 0923-7534, 7 p.Article

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern AfricaKEISER, Olivia; CHI, Benjamin H; WESTFALL, Andrew et al.AIDS (London). 2011, Vol 25, Num 14, pp 1761-1769, issn 0269-9370, 9 p.Article

Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)LEE, Daniel J; CHA, Eugene K; DUBIN, Justin M et al.BJU international (Papier). 2012, Vol 109, Num 7, pp 968-985, issn 1464-4096, 18 p.Article

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : Randomized phase 2 study of ixabepilone or mitoxantrone and prednisoneROSENBERG, Jonathan E; WEINBERG, Vivian K; KELLY, W. Kevin et al.Cancer. 2007, Vol 110, Num 3, pp 556-563, issn 0008-543X, 8 p.Article

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyESTEBAN, E; GONZALEZ DE SANDE, L; LACAVE, A. J et al.Annals of oncology. 2003, Vol 14, Num 11, pp 1640-1647, issn 0923-7534, 8 p.Article

A Randomized Phase 2 Trial of Erlotinib Versus Pemetrexed as Second-Line Therapy in the Treatment of Patients With Advanced EGFR Wild-Type and EGFR FISH-Positive Lung AdenocarcinomaNING LI; WEI OU; HUA YANG et al.Cancer. 2014, Vol 120, Num 9, pp 1379-1386, issn 0008-543X, 8 p.Article

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trialZHOU, Q; CHENG, Y; FENG, W.-N et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2385-2391, issn 0923-7534, 7 p.Article

Prognostic Value of Virological and Immunological Responses After 6 Months of Antiretroviral Treatment in Adults With HIV-1 Infection in Sub-Saharan AfricaDE LUCA, Andrea; CRISTINA MARAZZI, Maria; LIOTTA, Giuseppe et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 3, pp 236-244, issn 1525-4135, 9 p.Article

The causal effect of switching to second-line ART in programmes without access to routine viral load monitoringGSPONER, Thomas; PETERSEN, Maya; KEISER, Olivia et al.AIDS (London). 2012, Vol 26, Num 1, pp 57-65, issn 0269-9370, 9 p.Article

Biweekly Pegylated Liposomal Doxorubicin as Second-line Treatment in Patients with Relapsed Ovarian Cancer after Failure of Platinum and Paclitaxel : Results from a Multi-center Phase II Study of the NOGGOOSKAY-OEZCELIK, Guelten; KOENSGEN, Dominique; HINDENBURG, Hans-Joachim et al.Anticancer research. 2008, Vol 28, Num 2B, pp 1329-1334, issn 0250-7005, 6 p.Article

Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infectionMURAKAMI, Kazunari; SATO, Ryugo; OKIMOTO, Tadayoshi et al.Journal of gastroenterology and hepatology. 2006, Vol 21, Num 1, pp 262-267, issn 0815-9319, 6 p., 2Article

Meta-Analysis to Assess the Efficacy and Toxicity of Docetaxel-Based Doublet Compared with Docetaxel Alone for Patients with Advanced NSCLC who Failed First-Line TreatmentYING JIN; YAN SUN; XUN SHI et al.Clinical therapeutics. 2014, Vol 36, Num 12, pp 1980-1990, issn 0149-2918, 11 p.Article

Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysisESTILL, Janne; AUBRIERE, Cindy; HALLETT, Timothy B et al.AIDS (London). 2012, Vol 26, Num 11, pp 1403-1413, issn 0269-9370, 11 p.Article

Mitomycin C and vinorelbine for second-line chemotherapy in NSCLC - : a phase II trialBABIAK, A; HETZELL, J; GODDE, F et al.British journal of cancer. 2007, Vol 96, Num 7, pp 1052-1056, issn 0007-0920, 5 p.Article

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer : a multicenter phase II trialBOECK, S; WEIGANG-KÖHLER, K; KRÖNING, H et al.Annals of oncology. 2007, Vol 18, Num 4, pp 745-751, issn 0923-7534, 7 p.Article

High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillinRODRIGUEZ-TORRES, Maribel; SALGADO-MERCADO, Rosa; RIOS-BEDOYA, Carlos F et al.Digestive diseases and sciences. 2005, Vol 50, Num 4, pp 634-639, issn 0163-2116, 6 p.Article

  • Page / 3